5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.86▲ | 0.86▲ | 0.86▲ | 0.90▼ | 0.80▲ |
MA10 | 0.87▲ | 0.87▲ | 0.88▼ | 0.90▼ | 0.78▲ |
MA20 | 0.90▼ | 0.92▼ | 0.92▼ | 0.82▲ | 0.88▼ |
MA50 | 0.92▼ | 0.93▼ | 0.90▼ | 0.79▲ | 1.57▼ |
MA100 | 0.94▼ | 0.88▼ | 0.81▲ | 0.93▼ | 1.39▼ |
MA200 | 0.90▼ | 0.79▲ | 0.78▲ | 1.52▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.007▼ | -0.010▼ | 0.005▲ | 0.041▲ |
RSI | 41.867▼ | 43.503▼ | 45.331▼ | 53.011▲ | 42.387▼ |
STOCH | 77.703 | 43.841 | 31.554 | 51.338 | 46.297 |
WILL %R | -53.894 | -62.603 | -65.032 | -45.866 | -36.224 |
CCI | 17.090 | -33.499 | -44.510 | -23.614 | 76.016 |
Wednesday, April 30, 2025 04:30 AM
Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin Data supports ongoing Phase 1 clinical trial for CT-95 PHILADELPHIA, April 30, ...
|
Wednesday, April 30, 2025 12:36 AM
PHILADELPHIA - Context Therapeutics Inc. (NASDAQ:CNTX), a clinical-stage biopharmaceutical company with a market capitalization of approximately $79 million, announced promising preclinical data ...
|
Saturday, April 26, 2025 01:17 AM
CNX Resources Corporation beats earnings expectations. Reported EPS is $0.78, expectations were $0.64. Operator: Good day and welcome to the CNX Resources First Quarter 2025 Q&A Conference Call ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.87 | 0.8905 | 0.8201 | 0.8625 | 77,184 |
30/04/25 | 0.8814 | 0.8814 | 0.80 | 0.867 | 70,478 |
29/04/25 | 0.9401 | 0.9401 | 0.86 | 0.8722 | 18,338 |
28/04/25 | 0.93 | 0.99 | 0.9262 | 0.9401 | 40,959 |
25/04/25 | 0.97 | 0.9964 | 0.9201 | 0.94 | 56,388 |
24/04/25 | 0.99 | 1.015 | 0.8399 | 1.00 | 365,981 |
23/04/25 | 0.99 | 1.04 | 0.9256 | 0.9437 | 235,439 |
22/04/25 | 0.86 | 0.9599 | 0.86 | 0.9428 | 224,243 |
21/04/25 | 0.869 | 0.869 | 0.7885 | 0.834 | 95,047 |
17/04/25 | 0.86 | 0.86 | 0.81 | 0.8431 | 45,594 |
|
|
||||
|
|
||||
|
|